L-756423

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

HIV Infections

Phase 2

A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine

SuspendedNCT00002424

Merck Sharp & Dohme LLCHIV Infections

Target: 186Updated: 2005-06-24

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

CompletedNCT00002452

Merck Sharp & Dohme LLCHIV Infections

Target: 30Updated: 2005-06-24